✦ LIBER ✦

Development of neutralizing and binding antibodies to interferon (IFN) in patients undergoing IFN therapy

✍ Scribed by Guido Antonelli

Book ID: 118393394
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 594 KB
Volume: 24
Category: Article
ISSN: 0166-3542
DOI: 10.1016/0166-3542(94)90070-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fate of neutralizing and binding antibod

Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years

✍ Francesca Bellomi; Carolina Scagnolari; Valentina Tomassini; Claudio Gasperini; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Management of patients with neutralizing

Management of patients with neutralizing antibodies against interferon-beta: stop IFN-beta therapy or wait for the antibodies to go away?

✍ P. S. Sorensen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Further study on the specificity and inc

Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b

✍ Guido Antonelli; Eleonora Simeoni; Francesca Bagnato; Carlo Pozzilli; Ombretta T 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 66 KB

2-31-25 Development of neutralizing anti

2-31-25 Development of neutralizing antibodies in patients treated with IFN beta 1a

✍ C. Pozzili; G. Antonelli; F. Bagnato; E. Simeoni; S. Galgani; C. Gasperini; T. K 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Rapid and simple detection of IFN-neutra

Rapid and simple detection of IFN-neutralizing antibodies in chronic hepatitis C non-responsive to IFN-α

✍ Carl Jorns; Dirk Holzinger; Robert Thimme; Hans Christian Spangenberg; Manfred W 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB

## Abstract Different mechanisms have been proposed for the failure of interferon (IFN) therapy in patients with chronic hepatitis C and multiple sclerosis, for example, the presence of IFN‐neutralizing antibodies. In this study, a novel assay system based on the IFN‐inducible __Mx__‐promoter was u

Fate of antibody to interferon (IFN) in

Fate of antibody to interferon (IFN) in chronic hepatitis C patients treated with recombinant IFN alpha 2 and retreated with lymphoblastoid IFN alpha

✍ Guido Antonelli; Gianluigi Giannelli; Maurizio Currenti; Eleonora Simeoni; Miche 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 392 KB